Astria Therapeutics Inc (ATXS)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -12.39M | -14.29M | -13.49M | -15.1M | -20.24M | -34.2M | -24.15M | -28.8M |
税引前収入 | -12M | -13.26M | -11.19M | -12.57M | -17.73M | -31.41M | -19.93M | -24.17M |
純利益 | -12M | -13.26M | -11.19M | -12.57M | -17.73M | -31.41M | -19.93M | -24.17M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -12.45M | -14.28M | -13.51M | -15.12M | -20.25M | -34.21M | -24.17M | -28.82M |
EBITDA | -12.39M | -14.29M | -13.49M | -15.1M | -20.24M | -34.2M | -24.15M | -28.8M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 500k | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -35.56M | -27.09M | -26.37M | -27.09M | -37.44M | -194.98M | -53.5M | -83.03M |
税引前収入 | -36.06M | -27.36M | -25.87M | -26.29M | -37.3M | -194.91M | -51.83M | -72.89M |
純利益 | -36.06M | -27.36M | -25.87M | -26.29M | -37.3M | -194.91M | -51.83M | -72.89M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1.916 | -1.157 | -2.25 | -2.115 | -1.857 | -14.974 | -1.885 | -2.008 |
EBIT | -35.47M | -27.06M | -26.2M | -27.14M | -37.54M | -195.03M | -53.56M | -83.09M |
EBITDA | -35.16M | -26.79M | -26.25M | -27.06M | -37.44M | -194.98M | -53.5M | -83.03M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約